Assessing Ovarian Function During Prolonged Implant Use
common.study.values.description
“Assessing Ovarian Function During Prolonged Implant Use”
The study will evaluate how the ovaries may be functioning while using the the ImplanonAR/NexplanonAR during the three years beyond the FDA approved duration. Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws. Participants will be followed for 30 days.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Device - Etonogestrel Implant
Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws over a 30 day period. Participants will also complete a bleeding diary to assess daily bleeding patterns for the 30 day study period.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Assessing Ovarian Function During Prolonged Implant Use
common.study.values.clinical-trial-id
NCT03058978
participant.views.study.view.id
PdRJKd
